White Fund

White Fund is a venture capital firm based in Liège, Belgium, established in 2019, that specializes in early-stage investments in the medical device and medtech sectors. The firm focuses on companies that have demonstrated a proof of concept for their technology and have shown objective market traction. White Fund primarily targets investments within Belgium but may consider opportunities in neighboring regions. It typically invests between €2 million and €3 million in each project, spanning two to three rounds of financing, with an exit strategy aimed at five to seven years. The firm is dedicated to supporting the pre-marketing stages and the launch of sales for innovative healthcare solutions, including prevention, diagnostic, monitoring, and treatment technologies.

Michel Baijot

Chairman

Benoit Fellin

Fund Director

11 past transactions

Minze Health

Series A in 2024
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract problems, particularly focusing on urologic, pelvic health, and continence care. Its platform facilitates the diagnostic and treatment processes, as well as remote patient monitoring for individuals suffering from lower urinary tract symptoms (LUTS). Minze Health's innovative solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers around the globe, enabling healthcare professionals to effectively diagnose and monitor their patients both in clinical settings and private practices.

Clouds of care

Venture Round in 2024
Clouds of Care is a consulting firm that assists HealthTech companies throughout their development process, from algorithm validation to medical device software. The company specializes in regulatory compliance and aims to identify and eliminate barriers to market entry, facilitating the faster delivery of innovative technologies to patients. By leveraging its expertise in quality assurance, regulatory requirements, and software development, Clouds of Care provides valuable support to HealthTech firms, helping them navigate complex challenges and accelerate their journey to successful product implementation.

neuroClues

Seed Round in 2024
neuroClues is a medical technology company that offers an eye-tracking platform designed to assist practitioners in quantifying clinical examinations. The system extracts eye movement biomarkers, which aid neurologists in identifying Parkinsonian syndromes long before symptoms become apparent. By providing non-invasive and reliable biomarkers for central nervous system disorders, neuroClues enables healthcare professionals to detect neurological diseases early and monitor their progression effectively. This innovative approach aims to revolutionize the way neurological assessments are conducted, enhancing early diagnosis and patient care.

Axithra

Seed Round in 2023
Axithra is a company that specializes in therapeutic medication monitoring, specifically focusing on beta-lactam antibiotics. The business has developed a platform that enables rapid and accurate measurement of drug concentrations in the bloodstream, which is essential for personalized treatment in intensive care settings. By utilizing proprietary optical and photonics technology, Axithra's application allows healthcare providers to tailor antibiotic treatments to the individual needs of patients. This innovation aims to enhance patient care by ensuring that drug levels are monitored effectively, facilitating prompt adjustments to optimize therapeutic outcomes.

Minze Health

Seed Round in 2022
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract problems, particularly focusing on urologic, pelvic health, and continence care. Its platform facilitates the diagnostic and treatment processes, as well as remote patient monitoring for individuals suffering from lower urinary tract symptoms (LUTS). Minze Health's innovative solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers around the globe, enabling healthcare professionals to effectively diagnose and monitor their patients both in clinical settings and private practices.

Intressa Vascular

Funding Round in 2022
Intressa Vascular focuses on developing innovative solutions for cardiovascular conditions, particularly addressing aortic dissection. The company utilizes a proprietary braiding technology platform to create multilayer stents designed for next-generation endovascular treatments. These products assist physicians in effectively managing the serious impacts of aortic dissections, ultimately aiming to enhance patient outcomes while minimizing the risk of ischemic complications. By fostering a collaborative and constructive approach, Intressa Vascular is committed to advancing patient care through high-quality medical products.

Bingli

Series A in 2022
Bingli is a healthcare technology company that specializes in enhancing communication between patients and doctors through its innovative application. The application conducts smart pre-consultation interviews, allowing patients to accurately convey their symptoms to healthcare providers. This process not only prepares patients for their consultations but also enables physicians to save time, ultimately improving the quality of healthcare delivery. By streamlining the information-sharing process, Bingli aims to facilitate better patient outcomes and more efficient medical consultations.

MoveUP

Seed Round in 2021
MoveUP is a company focused on developing and commercializing digital therapeutics solutions designed to enhance healthcare delivery. Its innovative platform features a closed-loop system that ensures high compliance and improved outcomes for patients. By continuously collecting data, the platform personalizes treatment plans, significantly enhancing patient satisfaction. MoveUP's initial product targets orthopedic patients recovering from joint surgery, providing a user-friendly medical-grade mobile application that supports faster recovery. The company holds CE medical device and ISO 13485 certifications, underscoring its commitment to quality and regulatory standards in the healthcare sector.

Endo Tools Therapeutics

Series D in 2021
Endo Tools Therapeutics S.A. is a medical device company based in Gosselies, Belgium, founded in 2008. The company specializes in the development and manufacture of innovative therapeutic devices for gastroenterologists, focusing on flexible endoscopic interventions. Endo Tools Therapeutics is currently working on a catheter that will enhance therapeutic capabilities in interventional gastroenterology by adding therapeutic channels and degrees of freedom. The company's products aim to address conditions such as obesity, digestive tract tumors, and diabetes, enabling efficient surgical endoscopy through advanced techniques like flexible endoscopic suturing and tissue apposition. Additionally, the company has developed the ENDOMINA platform, which provides gastroenterologists with an open system for performing therapeutic procedures.

Antelope Dx

Series B in 2020
Antelope Dx BV is a Belgian company that specializes in developing innovative diagnostic products for home testing and point-of-care applications. Founded in 2018 and based in Zwijnaarde, Belgium, the company has created a palm-sized diagnostic device utilizing lab-on-chip technology. This platform enables users to perform high-quality tests on various bodily fluids with minimal operational complexity and no need for sample preparation. One of its key offerings is the Antelope Diagnostic STD-Test, a urine-based self-test that allows individuals to check for common sexually transmitted diseases, specifically Chlamydia trachomatis and Neisseria gonorrhoeae. Antelope Dx is also exploring diagnostic applications in fields such as animal health and drug development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.